Chronic colitis promotes tumor development

Oncology Reports

Volumn 15, Issue 6, 2006, Pages 1485-1490

  Shinozaki, Masaru ^a,b   Watanabe, Toshiaki ^a   Sato, Hajime ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Omori Red Cross Hospital   (Japan)

Author keywords

Cancer; Carcinogenesis; Colitis; Promotion

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETIC ACID; CARCINOGEN;

ANIMAL; ARTICLE; CELL GROWTH; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; COLORECTAL TUMOR; MALE; PATHOLOGY; PHYSIOLOGY; RAT; ULCERATIVE COLITIS; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; ACETIC ACID; ANIMALS; CARCINOGENS; CELL GROWTH PROCESSES; COCARCINOGENESIS; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; MALE; RATS; RATS, WISTAR;

EID: 34247622830     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.6.1485     Document Type: Article

References (26)

1. Ekbom A, Helmick CG, Zack M, Holmberg L, and Adami HO: Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 103: 954-960, 1992.
2. Mellemkjaer L, Olsen JH, Frisch M, et al: Cancer in patients with ulcerative colitis. Int J Cancer 60: 330-333, 1995.
3. Gyde SN, Prior P, Allen RN, et al: Colorectal cancer in ulcerative colitis: A cohort study of primary referrals from three centres. Gut 29: 206-217, 1988. (Pubitemid 18078890)
4. Lashner BA, Heidenreich PA, Su GL, Kane SV and Hanauer SB: Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 97: 255-259, 1989. (Pubitemid 19192158)
5. D'Haens GR, Lashner GR, and Hanauer SB: Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 88: 1174-1178, 1993. (Pubitemid 23219708)
6. Kahrilas PJ: Gastroesophageal reflux disease. JAMA 276: 983-988, 1996.
7. Bansal P and Sonnenberg A: Comorbid occurrence of cholelithiasis and gastrointestinal cancer. Eur J Gastroenterol Hepatol 8: 985-988, 1996. (Pubitemid 26356601)
8. Watanabe Y, Kurata JH, Mizuno S, et al: Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 42: 1383-1387, 1997. (Pubitemid 27339350)
9. Levin B: Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem 16G: 47-50 (suppl), 1992.
10. Pilot HC: Multistage carcinogenesis- Genetic and epigenetic mechanisms in relation to cancer prevention. Cancer Detect Prev 17: 567-563, 1993.
11. Yamada M, Ohkusa T and Okayasu I: Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulfate sodium. Gut 33: 1521-1527, 1992.
12. Hirono I, Ueno I, Aiso S, Yamaji T and Goldberg L: Enhancing effect of dextran sulfate sodium on colorectal carcinogenesis by 1,2-dimethylhydrazine in rats. Gann 74: 493-496, 1983. (Pubitemid 13003637)
13. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA and Lennard-Jones JE: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35: 1419-1423, 1994. (Pubitemid 24310904)
14. Hirono I, Kuhara K, Hosaka S, Tomizawa S and Goldberg L: Induction of intestinal tumors in rats by dextran sulfate sodium. J Natl Cancer Inst 66: 579-581, 1981.
15. Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Shimamoto F and Brown WR: Histochemical study of colonic cancer in experimental colitis of rats. Dig Dis Sci 38: 529-537, 1993. (Pubitemid 23087130)
16. Hirono I, Kuhara K, Yamaji T, Hosaka S and Goldberg L: Induction of colorectal squamous cell carcinoma in rats by dextran sulfate sodium. Carcinogenesis 3: 353-355, 1982. (Pubitemid 12088648)
17. Fabian RJ, Abraham R, Coulston F and Goldberg L: Carrageenan-induced squamous metaplasia of the rectal mucosa in the rat. Gastroenterology 65: 265-276, 1973.
18. Wakabayashi K, Inagaki T, Fujimoto Y and Fukuda Y: Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett 4: 171-176, 1978. (Pubitemid 8318396)
19. Kitano A, Matsumoto T, Hiki M, et al: Epithelial dysplasia of the rabbit colon induced by degraded carrageenan. Cancer Res 46: 1374-1376, 1996.
20. Davey PG, MaGuiness EE, Nicol S and Wormsley KG: Experimental colitis and colonic cancer in the rat. Mount Sinai J Med 52: 209-211, 1985. (Pubitemid 15079999)
21. Chester JF, Gaissert HA, Ross JS, Malt RA and Weitzmann SA: Colonic cancer induced by 1,2-dimethylhydrazine: promotion by experimental colitis. Br J Cancer 59: 704-705, 1989. (Pubitemid 19148528)
22. Hagihara PF: Experimental colitis as a promoter in large-bowel tumorigenesis. Arch Surg 117: 1304-1307, 1982.
23. Davis AE, Patterson F and Crouch R: The effect of therapeutic drugs used in inflammatory bowel disease on the incidence and growth of colonic cancer in the dimethylhydrazine rat model. Br J Cancer 66: 777-780, 1992.
24. Noffsinger AE, Miller MA, Cusi MV and Fenoglio PC: The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer 78: 2307-2312, 1996. (Pubitemid 26392828)
25. Kullmann F, Fadaie M, Gross V, et al: Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease. Eur J Gastroenterol Hepatol 8: 371-379, 1996. (Pubitemid 26171225)
26. Shinozaki M, Watanabe T, Kubota Y, Sawada T, Nagawa H and Muto T: High proliferative activity is associated with dysplasia in ulcerative colitis. Dis Colon Rectum 42 (suppl): S34-S39, 2000.